Screener
Kestra Medical Technologies KMTS Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | April 30, 2026 | April 30, 2025 |
|---|---|---|
| Operating lease liabilities, net of current portion | 4,111 | 3,026 |
| Warrant liabilities | 1,369 | 8,097 |
| Other long-term liabilities | 306 | 140 |
| Long-term debt, net | 42,649 | 41,098 |
| Total liabilities | 98,807 | 90,338 |
| Commitments and contingencies (Note 14) | ||
| Shareholders’ equity | ||
| Common Shares, $1.00 par value; 100,000,000 shares authorized as of April 30, 2026 and April 30, 2025; 58,383,924 issued and outstanding as of April 30, 2026 and 51,348,656 shares issued and outstanding as of April 30, 2025 | 58,384 | 51,349 |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's long-term debt?
- Kestra Medical Technologies (KMTS) reported long-term debt of $42.65M in Q1 2026.
- How has Kestra Medical Technologies's long-term debt changed year-over-year?
- Kestra Medical Technologies's long-term debt increased by 3.8% year-over-year, from $41.1M to $42.65M.
- What is the long-term trend for Kestra Medical Technologies's long-term debt?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's long-term debt has grown at a 0.1% compound annual growth rate (CAGR), from $42.54M to $42.65M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Kestra Medical Technologies's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude